Clinical trial Recruiting at 13 sites Interventional Ages 35 to 85

Multicenter stress cardiac MRI measuring heart muscle blood flow

Official title: The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States (SPINS2) Study

Run by Brigham and Women's Hospital · NCT06854458 · Data updated 2026-11-12

This will test whether detailed stress cardiac MRI blood-flow measurements help identify heart-related causes of chest pain or shortness of breath in adults 35–85 with suspected coronary artery disease.

More Magnetic Resonance Imaging trials

Quick facts

Study typeInterventional
Ages35 Years to 85 Years
SexAll
Enrollment1000 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations13 sites (San Francisco, California and 12 other locations)
StatusRecruiting
StartedJune 27, 2025
Main results expectedJanuary 2029
Study endsMarch 2029
Registry record updatedSeptember 1, 2026
Trial IDNCT06854458 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 35–85 who have chest pain or an anginal equivalent or an abnormal ECG with suspicion of coronary disease and intermediate or high pretest risk factors are the intended participants.

Probably not a fit

Patients without suspected ischemia, those with recent acute myocardial infarction within 30 days, standard contraindications to MRI or gadolinium, or very low pretest risk are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter study will enroll adults with chest pain or abnormal ECGs and intermediate-to-high risk features and perform standardized quantitative stress cardiac MRI across participating U.S. centers. Each participant will undergo vasodilator stress (regadenoson or adenosine) with gadolinium-based contrast (Gadavist 0.05 mmol/kg for stress and 0.05 mmol/kg for rest) to generate quantitative myocardial blood flow and flow reserve measurements alongside routine qualitative perfusion imaging. Investigators will compare quantitative perfusion indices to qualitative imaging and clinical risk factors to see whether abnormal blood-flow measurements predict higher rates of adverse cardiac events and better characterize multivessel disease. Results will be used to determine whether quantitative perfusion should influence decisions about invasive testing or early targeted medical therapy.

Why it matters

Potential benefit: If successful, this approach could help doctors more accurately detect reduced blood flow to the heart and better target invasive testing or preventive treatments to higher-risk patients.

How similar studies have gone: Prior smaller studies have suggested quantitative myocardial perfusion MRI can improve diagnostic accuracy, but this larger multicenter effort aims to validate those findings in a U.S. cohort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. male or female at age 35-85 years,
2. presence of either of the following sign/symptom that led to a referral to stress cardiac magnetic resonance imaging:

   1. chest pain or anginal equivalent, or
   2. abnormal electrocardiogram with a suspicion of coronary artery disease
3. Intermediate or high risk of significant coronary disease based on at least 1 of the following conditions:

   a) patient age \> 45 for male, 50 for female b) Diabetes, hypertension, or hypercholesterolemia: by either history or medical treatment c) family history of premature coronary disease: first degree relative at age \<= 55 male and \<=65 female d) history of smoking of \> 10 packed-years e) post-menopausal state \>5 years f) any chronic inflammatory conditions d) Body mass index \> 30 e) Any medical documentation of coronary or peripheral artery disease

Exclusion Criteria:

1. Acute myocardial infarction within the past 30 days prior to cardiac magnetic resonance imaging
2. Confirmed diagnosis of any significant non-coronary cardiac conditions below:

   1. any severe-grade valvular heart disease,
   2. left ventricular ejection fraction \<40% from any known non-coronary causes,
   3. infiltrative cardiomyopathy,
   4. hypertrophic cardiomyopathy,
   5. pericardial disease with significant constriction, or
3. active pregnancy,
4. any competing conditions leading to an expected survival of \< 2 years
5. contraindication to vasodilator (regadenoson or adenosine)
6. metallic device or object that poses an magnetic resonance imaging safety hazard
7. metallic device with a high likelihood of non-diagnostic cardiac magnetic resonance images

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting
  • UofL Health - Heart Hospital
    Louisville, Kentucky, United States
    Recruiting
  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Recruiting
  • St. Francis Hospital and Heart Center
    Roslyn, New York, United States
    Recruiting
  • Atrium Health - Sanger Heart & Vascular Institute
    Charlotte, North Carolina, United States
    Recruiting
Show 7 more locations
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • The Ohio State University
    Columbus, Ohio, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting
  • Houston Methodist Hospital
    Houston, Texas, United States
    Recruiting
  • University of Utah
    Salt Lake City, Utah, United States
    Recruiting
  • University of Virginia
    Charlottesville, Virginia, United States
    Recruiting
  • Virginia Commonwealth University
    Richmond, Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.